Literature DB >> 4515602

Concanavalin A derivatives with altered biological activities.

G R Gunther, J L Wang, I Yahara, B A Cunningham, G M Edelman.   

Abstract

Chemical derivatization of tetrameric concanavalin A (Con A) with succinic anhydride or acetic anhydride converts the protein to a dimeric molecule without altering its carbohydrate-binding specificity. At low concentrations, the dose-response curves for the mitogenic stimulation of mouse spleen cells by native Con A and succinyl-Con A are similar. Above lectin concentrations of 10 mug/ml, however, the response to Con A is diminished, while that for succinyl-Con A does not decrease until much higher doses are reached. We have attributed this difference mainly to the higher rate of cell death induced by the native Con A molecule. Con A also shows a greater capacity than succinyl-Con A to agglutinate sheep erythrocytes and to inhibit cap formation by immunoglobulin receptors on spleen cells. Moreover, at low concentrations, Con A induced its glycoprotein receptors to form caps, but succinyl-Con A did not induce cap formation. Addition of antibodies directed against Con A to succinyl-Con A bound on cells restored the properties of agglutination, inhibition of immunoglobulin receptor cap formation, and induction of cap formation by Con A receptors. Similar results have been obtained for acetyl-Con A. These data suggest that the altered biological activities of succinyl-Con A and acetyl-Con A are attributable to their reduced valence.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4515602      PMCID: PMC433414          DOI: 10.1073/pnas.70.4.1012

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Requirement for cross-linkage in the stimulation of transformation of rabbit peripheral lymphocytes by antiglobulin reagents.

Authors:  M W Fanger; D A Hart; J V Wells; A Nisonoff
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

3.  Inhibition of lymphocyte activation at high ratios of concanavalin A to serum depends on complement.

Authors:  P Milthorp; D R Forsdyke
Journal:  Nature       Date:  1970-09-26       Impact factor: 49.962

4.  Reversible interaction of human lymphocytes with the mitogen concanavalin A.

Authors:  A E Powell; M A Leon
Journal:  Exp Cell Res       Date:  1970-10       Impact factor: 3.905

5.  Lymphocyte transformation induced by concanavalin A and its reversion by methyl-alpha-D-mannopyranoside.

Authors:  A Novogrodsky; E Katchalski
Journal:  Biochim Biophys Acta       Date:  1971-01-28

6.  Binding of diffusible molecules by macromolecules: rapid measurement by rate of dialysis.

Authors:  S P Colowick; F C Womack
Journal:  J Biol Chem       Date:  1969-02-25       Impact factor: 5.157

7.  Chromatographic purification of tetramethylrhodamine-immune globulin conjugates and their use in the cellular localization of rabbit gamma-globulin polypeptide chains.

Authors:  J J Cebra; G Goldstein
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

8.  Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro.

Authors:  M F Woodruff; B Reid; K James
Journal:  Nature       Date:  1967-08-05       Impact factor: 49.962

9.  Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells.

Authors:  M Inbar; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  98 in total

1.  The isolation and properties of the dimeric subunit of concanavalin A.

Authors:  J H Pazur; M D Perloff; A R Frymoyer; C J Jensen; H Micolochick; A Mastro
Journal:  J Protein Chem       Date:  2000-07

2.  Growth stimulation of tumor-specific cytotoxic T lymphocytes on concanavalin a-immobilized carrier beads.

Authors:  S Q Liu; L S Liu; T Ohno
Journal:  Cytotechnology       Date:  1998-01       Impact factor: 2.058

3.  Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.

Authors:  E N Kaufman; R K Jain
Journal:  Biophys J       Date:  1990-10       Impact factor: 4.033

4.  Mechanism of human lymphocyte stimulation by concanavalin A: role of valence and surface binding sites.

Authors:  J R Wands; D K Podolsky; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

5.  Mobility of cholera toxin receptors on rat lymphocyte membranes.

Authors:  S W Craig; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

6.  Lateral transport on cell membranes: mobility of concanavalin A receptors on myoblasts.

Authors:  J Schlessinger; D E Koppel; D Axelrod; K Jacobson; W W Webb; E L Elson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

7.  Clustering and endocytosis of membrane receptors can be induced in mature erythrocytes of neonatal but not adult humans.

Authors:  R Schekman; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

8.  Possible mechanism for flocculation interactions governed by gene FLO1 in Saccharomyces cerevisiae.

Authors:  B L Miki; N H Poon; A P James; V L Seligy
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

9.  Myosin II is involved in capping and uroid formation in the human pathogen Entamoeba histolytica.

Authors:  P Arhets; P Gounon; P Sansonetti; N Guillén
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Inhibition by colchicine of the mitogenic stimulation of lymphocytes prior to the S phase.

Authors:  J L Wang; G R Gunther; G M Edelman
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.